Back to VA VANGUARD CAPITAL MANAGEMENT LLC
IKT2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in INHIBIKASE THERAPEUTICS INC
Yes. Vanguard Capital Management holds 4,935,354 shares of IKT (Inhibikase Therapeutics), worth $10M, as of its Q2 2026 13F filing. It increased the position by 484,689 shares (+10.9%) from Q1 2026. Vanguard Capital Management has held IKT in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$10M
Current Shares
4.9M
Total Value Change
+$2.5M
Total Shares Change
+484,689
Quarter-by-Quarter History
Other major holders of IKT: BlackRock, Inc., Blackstone Inc.